Stock market analysts have suggested investors to ‘sell’ Axis Bank stock as there are full chances of a downward trend in this stock in the coming days.

According to them, investors can sell the stock with a strict stop loss of Rs 536 to achieve a target that lies between Rs 520-516.

Today (April 29), the stock opened at Rs 548.95 on the Bombay Stock Exchange (BSE). Current EPS & P/E ratio stood at 50.56 and 10.65 respectively. The share price has seen a 52-week high of Rs 969.90 and a low of Rs 278.50 on BSE.

Struggling with the impact devaluation of rupee on its business, the Honda Siel Cars India, Limited (HSCI) is looking to hike Honda CR-V prices in India. The HSCI has disclosed that the Honda CR-V prices could be increased by 30 percent in India. The HSCI is joint venture between the Honda Motor Company Limited, Japan and Siel Limited, a Siddharth Shriram Group company.  

To increase its attentiveness and block up swine influenza virus’ entry into India, the government has began taking desperate steps to battle and contain it.

The administration on Tuesday announced that it would ask drug makers comprising Cipla, Ranbaxy, Natco and Hyderabad-based Hetero Drugs to start storing the chemicals needed to create the drug to fight deadly influenza.

Moreover, the Airports Authority of India (AAI) would also issue additional passes to health workers in order to check people with flu symptoms at nine airports.

The flagship company of the Reliance-Anil Dhirubhai Ambani Group— Reliance Communications (RCom) on Tuesday rolled out new Magic Tariff offer – “Magic@Re 1” – for its CDMA subscribers in Karnataka.

“Magic@Re 1,” the RCom Magic Tariff on a daily basis offer, allows CDMA subscribers to make calls at cheaper rates by paying Rs 1 daily. Yes, by just paying a rental fee of Rs 1 per day, the RCom CDMA subscribers can make local calls at 60 paise per minute and STD calls at Re 1.20 per minute.
   
The new RCom CDMA subscribers can enjoy the “Magic@Re 1” offer by recharging their prepaid mobile with Rs 26. The existing customers can also enjoy the offer by recharging with Rs.34 voucher.

Glenmark Pharmaceuticals announced that it has received tentative approval from the U.S. Food and Drug Administration (FDA) to sell the generic version of Schering Plough and MSP Singapore Company LLC’s hypercholesterolemia treatment Zetia (ezetimibe) in the United States.

Glenmark, which has got sanction for 10-milligram tablets of the drug, is likely to get 180 days marketing exclusivity for the drug upon patent expiry.

Zetia recorded sales of $1.5 billion during the last year (2008), the drug maker said in a statement.

ABB, a leader in power and automation technologies, has secured substation orders worth Rs 425 crore from Powergrid, Country's largest power distributor, to boost capacity and help improve grid reliability.

The scope of contract includes design, supply, installation and commissioning of 765/400 kilovolt (kV) substations at Agra (Uttar Pradesh), Wardha (Maharashtra), Bilaspur and Seoni (both Madhya Pradesh), and of a 400/220 kV substation at Palakkad (Kerala).

The projects are expected to be completed by mid-2011.